|
|
|
| Take a tour of Nanoform's best-in-class nanodevelopment capabilities, setting new standards in innovation. Their highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. With 14 development lines for small molecules and 5 for large molecules, Nanoform offers unmatched scalability and precision. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers. Learn more. |
|
|
|
|
By Drug Delivery Leader: Sit And Deliver | In this Sit and Deliver episode, host Tom von Gunden talks with Chief Scientific Officer Karl Thor of Dignify Therapeutics about orally administered and suppository-based approaches to relieve patients suffering from neurogenic bowel and bladder dysfunction. | |
|
|
Use-Related Risk Analysis: Considering The FDA Guidance On URRA | By Fran DeGrazio, Drug Delivery Leader | The FDA draft guidance on Use-Related Risk Analysis (URRA) announced in July 2024 helpfully clarified key considerations regarding the identification and mitigation of potential hazards in biopharmaceutical product use. In this article, Fran DeGrazio comments on the guidance in a follow-up to a Drug Delivery Live! online event she moderated on the topic of URRA. |
|
|
|
|
|
|
|
| Best Practices For Outsourcing Injectables Manufacturing | Q&A | Simtra BioPharma Solutions | Contract manufacturers play an important role in helping pharmaceutical and biotech companies bring their products to market. Discover key considerations when outsourcing an injectable project. |
|
|
|
|
|
|
|
|
|
|
|
|
| Join experts in drug delivery innovation as they discuss advancements in long-standing devices, systems, and platforms. Covering technologies like autoinjectors, infusion pumps, OBS, combination products, and connected devices, this virtual panel discussion will explore technical and functional innovation needs, challenges, and successes. Register today for Drug Delivery Leader Live happening May 7th! |
|
|
.png){kind=logo}
